Internship

MSAT Intern

Posted on 3/13/2024

Arcellx

Arcellx

51-200 employees

Develops immunotherapies for cell therapy

Biotechnology
Healthcare

North Bethesda, MD, USA + 1 more

More locations: San Carlos, CA, USA

Category
Lab & Research
Interdisciplinary Research
Life Sciences
Required Skills
PowerPoint/Keynote/Slides

You match the following Arcellx's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Enrolled in undergraduate or graduate program at the time of the internship
  • Basic understanding of Chemistry/Biology or at least taken courses in science field
  • Experience with Microsoft Office applications like Word, Excel, Powerpoint is preferred
  • Basic Laboratory skills and necessary interpersonal skills to collaborate
  • Attention to details and following instructions written in a Batch Record/Standard Operating Procedure
Responsibilities
  • Laying the foundation for transitioning from paper based to Digital Master Batch Records for CAR-T Manufacturing platform
  • Understanding and familiarization with existing paper based Master Batch Records for CAR-T Process
  • Electronic Batch Record Training
  • Learning Platform and Integration of current MBR into electronic MBR
  • Proof-of concept studies and execution of the e-BR in PD/MSAT Lab

Arcellx develops immunotherapies aimed at improving cell therapy for serious diseases. Their products focus on advanced techniques that harness the body's immune system to fight illnesses. The company collaborates with healthcare providers and research institutions to create and test these therapies, generating revenue through partnerships and licensing agreements. What sets Arcellx apart from competitors is its commitment to addressing unmet medical needs with proprietary treatments that prioritize safety and effectiveness. The ultimate goal of Arcellx is to provide innovative treatment options that can significantly improve patient outcomes.

Company Stage

IPO

Total Funding

$194.5M

Headquarters

Gaithersburg, Maryland

Founded

2014

Growth & Insights
Headcount

6 month growth

4%

1 year growth

0%

2 year growth

1%
Simplify Jobs

Simplify's Take

What believers are saying

  • Strategic partnership with Kite accelerates development and commercialization of therapies.
  • FDA support expedites approval process for Arcellx's innovative treatments.
  • Advancements in gene editing enhance precision of Arcellx's cell therapies.

What critics are saying

  • Competition from established CAR-T therapies like Abecma and Carvykti.
  • Dependency on Kite partnership could pose risks if dynamics change.
  • Phase 3 trial for anito-cel carries risk of not meeting endpoints.

What makes Arcellx unique

  • Arcellx's CART-ddBCMA has FDA Fast Track, Orphan Drug, and RMAT designations.
  • The ARC-SparX platform offers dosable and controllable CAR-T therapy options.
  • Anito-cel uses a novel D-Domain BCMA binder for enhanced antigen binding.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Unlimited Paid Time Off

Flexible Work Hours

401(k) Company Match

Fully-Paid Parental Leave

Tuition Reimbursement

Relocation Assistance

INACTIVE